SciGen has recognised the huge potential of the Biopharmaceutical market, which is currently growing faster than any other market in the Healthcare industry. With a combination of shared wealth and increasing life expectancy of the world's population, the Biopharmaceutical market is expected to continue to grow much faster than other world markets, providing a strong foundation for SciGen's extensive biotechnological expertise and sound marketing infrastructure.
In view of the strong government support for the biotechnology sector, SciGen has adopted an approach to its product development which, in keeping with
government initiatives, endeavours to supply competitively priced, state-of-the-art healthcare products to the greatest majority of the world's population.
- Forums
- ASX - By Stock
- *** another announcement ***
SciGen has recognised the huge potential of the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SIE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online